These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6404136)

  • 1. Circulating immune complexes in end-stage renal disease: comparative and kinetic studies of various types of complexes.
    Favre H; Glasson P; Perez GO; Lambert PH; Leski M
    Adv Nephrol Necker Hosp; 1983; 12():205-13. PubMed ID: 6404136
    [No Abstract]   [Full Text] [Related]  

  • 2. Complement activation and C1q binding activity in haemodialysis.
    Dodd NJ; Vergani D; Turney JH; Parsons V; Weston MJ
    Proc Eur Dial Transplant Assoc; 1981; 18():300-4. PubMed ID: 6977138
    [No Abstract]   [Full Text] [Related]  

  • 3. Auto-immunity in patients with end-stage renal disease maintained on hemodialysis and continuous ambulatory peritoneal dialysis.
    Gagnon RF; Shuster J; Kaye M
    J Clin Lab Immunol; 1983 Jul; 11(3):155-8. PubMed ID: 6604164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Circulating immune complexes in a population of subjects seropositive for rheumatoid factor].
    Aureli G; Battista V; Bianchi L; Bolzonetti A; Cipriani A; Carnevali GF; Caschera F; Caputo B; Danieli G; Corvetta A
    Boll Ist Sieroter Milan; 1982; 61(5):367-74. PubMed ID: 6985415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating immune complexes in regularly dialyzed patients with chronic renal failure.
    Perez GO; Glasson P; Favre H; Wauters JP; Benzonana G; Jeannet M; Lambert PH
    Am J Nephrol; 1984; 4(4):215-21. PubMed ID: 6236693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Analysis of circulating immune complexes with reference to DNA complexes in patients on hemodialysis and in those with chronic renal failure].
    Kozioł M; Ksiazek A; Majdan M; Solski J
    Pol Arch Med Wewn; 1988 Dec; 80(6):315-22. PubMed ID: 3270816
    [No Abstract]   [Full Text] [Related]  

  • 7. Evidence against an immune complex pathogenesis of primary biliary cirrhosis.
    Goldberg MJ; Kaplan MM; Mitamura T; Anderson CL; Matloff DS; Pinn VW; Agnello V
    Gastroenterology; 1982 Sep; 83(3):677-83. PubMed ID: 6212278
    [No Abstract]   [Full Text] [Related]  

  • 8. Immune complexes in diabetes mellitus: studies of complement utilisation and tissue deposition.
    Charlesworth JA; Campbell LV; Catanzaro R; Pussell BA; Pasterfield GV; Peake P
    J Clin Lab Immunol; 1982 Sep; 8(3):163-8. PubMed ID: 6752415
    [No Abstract]   [Full Text] [Related]  

  • 9. [Methods of determining circulating immune complexes].
    Baleva M
    Vutr Boles; 1983; 22(6):1-5. PubMed ID: 6369791
    [No Abstract]   [Full Text] [Related]  

  • 10. [Determination of circulating immune complexes in rheumatoid arthritis: comparison of 2 immunoenzyme methods].
    Bernardoni R; Soffritti E; Pelizzola D; Pazzi A; Accardo G
    Riv Emoter Immunoematol; 1985; 32(1):58-68. PubMed ID: 3909362
    [No Abstract]   [Full Text] [Related]  

  • 11. Circulating immune complexes in sera of patients infected with Echinococcus granulosus.
    Pini C; Pastore R; Valesini G
    Clin Exp Immunol; 1983 Mar; 51(3):572-8. PubMed ID: 6406114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating immune complexes: a review.
    Newman JH
    Del Med J; 1983 Sep; 55(9):507-12. PubMed ID: 6357874
    [No Abstract]   [Full Text] [Related]  

  • 13. A comparative study of complement components in polyethylene glycol precipitated immune complexes from patients with ovarian cancer and patients with rheumatoid arthritis.
    Mooney NA; Hay FC; Poulton TA
    Clin Exp Immunol; 1983 Jun; 52(3):561-8. PubMed ID: 6603297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating immune complexes in Behçet's disease.
    Inoue T; Oniki S; Kajiyama K; Jimi S
    Jpn J Ophthalmol; 1983; 27(1):35-9. PubMed ID: 6602236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential precipitation of the Clq subcomponent of the first complement component (C1) by polyethylene glycol from normal human serum and sera of patients with collagen diseases.
    Van Dijk H; Van Voorst J; Jankowski IG; Imhof JW; Kerckhaert JA
    Clin Exp Immunol; 1984 Aug; 57(2):495-501. PubMed ID: 6432386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between circulating immune complexes and renal disease in New Zealand mice.
    Nakai Y; Yoshida H; Maruyama N; Shirai T; Hamashima Y
    Clin Exp Immunol; 1981 Feb; 43(2):240-5. PubMed ID: 6974065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Is the demonstration of immune complex useful in the activity assessment of chronic polyarthritis?].
    Schlumpf U; Ernst R; Christen P; von Felten A; Böni A
    Schweiz Med Wochenschr; 1984 Jan; 114(4):118-30. PubMed ID: 6367028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunologic alterations associated with chronic hemodialysis.
    Rus HG; Cristea A; Gherman M; Niculescu F; Gavan M
    Med Interne; 1983; 21(4):289-95. PubMed ID: 6658343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating immune complexes detected by C1q solid phase assay in leprosy.
    Nuti M; D'Amelio R; Seminara R; Milano CF; Palmisano L; Aiuti F
    Int J Lepr Other Mycobact Dis; 1981 Mar; 49(1):27-30. PubMed ID: 6972924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between the articular manifestations of rheumatoid arthritis and circulating immune complexes detected by three methods and specific classes of rheumatoid factors.
    Lessard J; Nunnery E; Cecere F; McDuffy S; Pope RM
    J Rheumatol; 1983 Jun; 10(3):411-7. PubMed ID: 6604160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.